• Designing modular, small-scale manufacturing systems tailored for patient-specific mRNA constructs, including rare diseases and personalized immunotherapies
• Applying engineering principles to streamline upstream and downstream workflows, reducing footprint, cost, and turnaround time
• Harnessing real-time monitoring tools into compact production platforms to ensure batch consistency and compliance

NEW COMPANY